LobbyingAmerican College of Surgeons lobbying by quarter
American College of Surgeons's latest lobbying report covers Q2 2026, at $300K. The four quarters Q4 2025–Q3 2026 total $880K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
American College of Surgeons
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $880K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $296K | 2 |
| Q1 2023 | $298K | 2 |
| Q2 2023 | $290K | 2 |
| Q3 2023 | $260K | 2 |
| Q4 2023 | $310K | 2 |
| Q1 2024 | $270K | 2 |
| Q2 2024 | $280K | 2 |
| Q3 2024 | $280K | 2 |
| Q4 2024 | $280K | 2 |
| Q1 2025 | $290K | 2 |
| Q2 2025 | $270K | 2 |
| Q3 2025 | $240K | 2 |
| Q4 2025 | $260K | 2 |
| Q1 2026 | $320K | 2 |
| Q2 2026 | $300K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$1.8M · 30 reports
- Medicare and Medicaid$914.7K · 15 reports
- Budget and appropriations$795.7K · 14 reports
- Veterans$719K · 13 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES30 reports
- SENATE30 reports
- Centers For Medicare and Medicaid Services (CMS)15 reports
- Health & Human Services, Dept of (HHS)15 reports
- Veterans Affairs, Dept of (VA)13 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAmerican College of Surgeons | $3.3M | 15 quarters |
| Hart Health Strategies | $900K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JUDITH GORSUCH | Senator Jon Kyl | Q2 2026 |
| TIMOTHY YEHL | Senator Frank Lautenberg | Q2 2026 |
| VICKI HART | Senator Bob Dole | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Hart Health Strategies | $60K |
| 07/16for Q2 | In-house | $240K |
| 04/20for Q1 | Hart Health Strategies | $60K |
| 04/17for Q1 | In-house | $260K |
| 01/20for Q4 2025 | In-house | $200K |
| 01/16for Q4 2025 | Hart Health Strategies | $60K |
| 25/10/20for Q3 2025 | Hart Health Strategies | $60K |
| 25/10/16for Q3 2025 | In-house | $180K |
| 25/07/14for Q2 2025 | In-house | $210K |
| 25/07/10for Q2 2025 | Hart Health Strategies | $60K |
| 25/04/18for Q1 2025 | Hart Health Strategies | $60K |
| 25/04/16for Q1 2025 | In-house | $230K |
| 25/01/16for Q4 2024 | In-house | $220K |
| 25/01/05for Q4 2024 | Hart Health Strategies | $60K |
| 24/10/15for Q3 2024 | In-house | $220K |
| 24/10/10for Q3 2024 | Hart Health Strategies | $60K |
| 24/07/21for Q2 2024 | Hart Health Strategies | $60K |
| 24/07/09for Q2 2024 | In-house | $220K |
| 24/04/22for Q1 2024 | Hart Health Strategies | $60K |
| 24/04/09for Q1 2024 | In-house | $210K |